| 1. |
Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet, 2005, 365(9453): 82-93.
|
| 2. |
Gross CP, Mallory R, Heiat A, et al. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med, 2002, 137(1): 10-16.
|
| 3. |
Persaud N, Mamdani MM. External validity: the neglected dimension in evidence ranking. J Eval Clin Pract, 2006, 12(4): 450-453.
|
| 4. |
Steg PG, López-Sendón J, Lopez de Sa E, et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med, 2007, 167(1): 68-73.
|
| 5. |
卫生部心血管病防治研究中心. 中国心血管病报告2005. 北京: 中国大百科全书出版社, 2006. 84-94.
|
| 6. |
Britton A, McKee M, Black N, et al. Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy, 1999, 4(2):112-121.
|
| 7. |
Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Stat Med, 1999, 18(19): 2605-2615.
|
| 8. |
Petersen MK, Andersen KV, Andersen NT, et al. "To whom do the results of this trial apply?" External validity of a randomized controlled trial involving 130 patients scheduled for primary total hip replacement. Acta Orthop, 2007, 78(1): 12-18.
|
| 9. |
Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med, 1996, 334(21): 1349-1355.
|
| 10. |
Uijen AA, Bakx JC, Mokkink HG, et al. Hypertension patients participating in trials differ in many aspects from patients treated in general practices. J Clin Epidemiol, 2007, 60(4): 330-335.
|
| 11. |
Coca SG, Krumholz HM, Garg AX, et al. Under-representation of renal disease in randomized controlled trials of cardiovascular disease. JAMA, 2006, 296(11): 1377-1384.
|
